Express News | Applied DNA Sciences Partners With GenXys Health Care Systems To Enhance Precision Prescribing With TR8 Pharmacogenomic Test; Aims To Improve Patient Outcomes And Reduce Healthcare Costs Through Data-Driven Genetic Analysis

BenzingaJun 18 09:11 ET

Applied DNA Partners With GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing

Partnership Will Aid Physicians in Precision Prescribing Decisions Based on Applied DNA's TR8 Pharmacogenomic (PGx) Test STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc. (NASD

AccesswireJun 18 09:00 ET

Express News | Applied DNA Receives Approval for Tr8(Tm) Pharmacogenomic (Pgx) Testing Service From New York State Department of Health

ReutersJun 13 09:05 ET

Express News | New York State Department Of Health Approved Applied DNA For TR8 Pharmacogenomic Testing Service

BenzingaJun 13 09:04 ET

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service From New York State Department of Health

STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York Stat

AccesswireJun 13 09:00 ET

Applied DNA Sciences Is Maintained at Buy by HC Wainwright & Co.

Applied DNA Sciences Is Maintained at Buy by HC Wainwright & Co.

Dow JonesJun 10 07:56 ET